IL6 and inflammatory bowel disease: Akkermansia muciniphila-derived EVs were shown to inhibit the production of IL-6 from colon epithelial cells and reduce mucosal inflammation in an IBD mouse model [122], and Lactobacillus-derived EVs have been proposed as a therapy for IBD and other AIDs [123].